Aier Eye Hospital Group Co., Ltd. (300015.SZ)
CNY 12.98
(-0.15%)
CNY 12.98
(-0.15%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 3.35 Billion CNY | 33.07% |
| 2022 | 2.52 Billion CNY | 8.65% |
| 2021 | 2.32 Billion CNY | 34.78% |
| 2020 | 1.72 Billion CNY | 25.01% |
| 2019 | 1.37 Billion CNY | 36.67% |
| 2018 | 1 Billion CNY | 35.88% |
| 2017 | 742.51 Million CNY | 33.19% |
| 2016 | 557.46 Million CNY | 30.24% |
| 2015 | 428.04 Million CNY | 38.44% |
| 2014 | 309.18 Million CNY | 38.34% |
| 2013 | 223.49 Million CNY | 22.43% |
| 2012 | 182.54 Million CNY | 6.18% |
| 2011 | 171.92 Million CNY | 42.9% |
| 2010 | 120.3 Million CNY | 30.08% |
| 2009 | 92.48 Million CNY | 50.72% |
| 2008 | 61.36 Million CNY | 57.43% |
| 2007 | 38.97 Million CNY | 167.14% |
| 2006 | 14.59 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 899.47 Million CNY | 406.42% |
| 2024 Q2 | 1.15 Billion CNY | 27.9% |
| 2024 Q3 | 1.4 Billion CNY | 21.86% |
| 2023 FY | 3.35 Billion CNY | 33.07% |
| 2023 Q3 | 1.46 Billion CNY | 57.72% |
| 2023 Q4 | 177.61 Million CNY | -87.91% |
| 2023 Q2 | 931.3 Million CNY | 19.24% |
| 2023 Q1 | 781.06 Million CNY | 573.94% |
| 2022 Q3 | 1.06 Billion CNY | 56.58% |
| 2022 FY | 2.52 Billion CNY | 8.65% |
| 2022 Q1 | 610.6 Million CNY | 90.9% |
| 2022 Q2 | 680.67 Million CNY | 11.48% |
| 2022 Q4 | 115.89 Million CNY | -89.13% |
| 2021 Q3 | 887.71 Million CNY | 40.51% |
| 2021 Q2 | 631.76 Million CNY | 30.52% |
| 2021 Q1 | 484.02 Million CNY | 172.27% |
| 2021 FY | 2.32 Billion CNY | 34.78% |
| 2021 Q4 | 319.84 Million CNY | -63.97% |
| 2020 Q2 | 596.76 Million CNY | 651.94% |
| 2020 Q3 | 869.9 Million CNY | 45.77% |
| 2020 Q4 | 177.76 Million CNY | -79.56% |
| 2020 FY | 1.72 Billion CNY | 25.01% |
| 2020 Q1 | 79.36 Million CNY | -46.39% |
| 2019 Q3 | 535.86 Million CNY | 35.15% |
| 2019 Q1 | 298.51 Million CNY | 161.62% |
| 2019 FY | 1.37 Billion CNY | 36.67% |
| 2019 Q4 | 148.03 Million CNY | -72.37% |
| 2019 Q2 | 396.5 Million CNY | 32.83% |
| 2018 Q1 | 216.56 Million CNY | 97.2% |
| 2018 Q3 | 385.76 Million CNY | 31.89% |
| 2018 Q4 | 114.1 Million CNY | -70.42% |
| 2018 FY | 1 Billion CNY | 35.88% |
| 2018 Q2 | 292.49 Million CNY | 35.06% |
| 2017 Q3 | 270.65 Million CNY | 31.13% |
| 2017 Q4 | 109.82 Million CNY | -59.42% |
| 2017 FY | 742.51 Million CNY | 33.19% |
| 2017 Q1 | 155.62 Million CNY | 74.83% |
| 2017 Q2 | 206.4 Million CNY | 32.63% |
| 2016 FY | 557.46 Million CNY | 30.24% |
| 2016 Q1 | 118.64 Million CNY | 70.37% |
| 2016 Q2 | 154.1 Million CNY | 29.89% |
| 2016 Q3 | 195.7 Million CNY | 26.99% |
| 2016 Q4 | 89.01 Million CNY | -54.52% |
| 2015 Q4 | 69.64 Million CNY | -55.46% |
| 2015 Q3 | 156.34 Million CNY | 36.77% |
| 2015 Q2 | 114.3 Million CNY | 30.26% |
| 2015 Q1 | 87.75 Million CNY | 61.73% |
| 2015 FY | 428.04 Million CNY | 38.44% |
| 2014 Q2 | 78.5 Million CNY | 19.71% |
| 2014 FY | 309.18 Million CNY | 38.34% |
| 2014 Q4 | 54.25 Million CNY | -51.05% |
| 2014 Q3 | 110.83 Million CNY | 41.19% |
| 2014 Q1 | 65.58 Million CNY | 58.11% |
| 2013 Q4 | 41.47 Million CNY | -48.21% |
| 2013 FY | 223.49 Million CNY | 22.43% |
| 2013 Q1 | 48.72 Million CNY | 41.39% |
| 2013 Q2 | 53.23 Million CNY | 9.26% |
| 2013 Q3 | 80.08 Million CNY | 50.43% |
| 2012 Q1 | 47.59 Million CNY | 26.71% |
| 2012 Q4 | 34.46 Million CNY | -39.0% |
| 2012 Q3 | 56.49 Million CNY | 28.41% |
| 2012 Q2 | 43.99 Million CNY | -7.55% |
| 2012 FY | 182.54 Million CNY | 6.18% |
| 2011 Q3 | 54.53 Million CNY | 25.63% |
| 2011 Q1 | 36.42 Million CNY | 12.82% |
| 2011 Q2 | 43.41 Million CNY | 19.2% |
| 2011 Q4 | 37.55 Million CNY | -31.13% |
| 2011 FY | 171.92 Million CNY | 42.9% |
| 2010 FY | 120.3 Million CNY | 30.08% |
| 2010 Q2 | 26 Million CNY | -1.15% |
| 2010 Q1 | 26.3 Million CNY | 30.21% |
| 2010 Q3 | 35.72 Million CNY | 37.39% |
| 2010 Q4 | 32.28 Million CNY | -9.63% |
| 2009 Q1 | 16.97 Million CNY | 38.83% |
| 2009 FY | 92.48 Million CNY | 50.72% |
| 2009 Q4 | 20.2 Million CNY | -31.3% |
| 2009 Q3 | 29.4 Million CNY | 13.52% |
| 2009 Q2 | 25.9 Million CNY | 52.63% |
| 2008 FY | 61.36 Million CNY | 57.43% |
| 2008 Q3 | 22.03 Million CNY | 0.0% |
| 2008 Q4 | 12.22 Million CNY | -44.52% |
| 2007 FY | 38.97 Million CNY | 167.14% |
| 2006 FY | 14.59 Million CNY | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| C.Q. Pharmaceutical Holding Co., Ltd. | 654.95 Million CNY | -412.839% |
| Meinian Onehealth Healthcare Holdings Co., Ltd. | 505.62 Million CNY | -564.306% |